Healthcare & Life Sciences

AmCham Germany discusses current healthcare policies in its Healthcare and Life Sciences Committee. The committee represents the interests of all healthcare industries within AmCham Germany’s membership. Ranging from pharmaceutical research companies to medical technology and diagnostics as well as IT firms and the consumer health sector, the committee’s mission is to speak with one voice for the entire healthcare sector.

It addresses current healthcare topics and engages in stakeholder discussions on the future of the German healthcare market. The committee maintains a clear, constructive and open dialogue with all relevant policy and decision-makers on the regional and federal level as well as on the European level depending on the issues. All major developments are monitored closely. The Healthcare and Life Sciences Committee focuses on regulatory issues related to healthcare and pharmaceutical products and seeks to promote a less regulated market, a friendlier investment climate, and further research opportunities within Germany. 

Note: Until June 2017, the Healthcare and Life Sciences Committee consisted of two committees: Health Care and Business of Healthcare.

Healthcare News

Health Care

Business of Healthcare Committee meets with Kordula Schulz-Asche, MdB

On 23 June, 2016 members of AmCham Germany’s Business of Healthcare Committee met with Kordula Schulz-Asche, MdB, Sprecherin für Prävention und...

Health Care

Parliamentary Breakfast on the Medical Progress in Oncology

Medical Progress in Oncology and its Added Value for Cancer Patients

Health Care

TTIP: Common Standards are Key Drivers for Pharmaceutical Sector

Guest Article by Simone Thomsen, General Manager, Lilly Deutschland GmbH

Healthcare & Life Sciences Committee

AmCham Germany discusses current healthcare policies in its Healthcare and Life Sciences Committee. The committee represents the interests of all healthcare industries within AmCham Germany’s membership.

Downloads

Stellungnahme: Ein Plädoyer für offene Märkte und pluralistische Strukturen Positionen der industriellen Gesundheitswirtschaft zur Gesundheitsversorgung

PDF 912.18 KB

Diskussionspapier "Big Data und E-Health: Erfahrungswerte aus der transatlantischen Gesundheitswirtschaft“

PDF 1.21 MB

Stellungnahme "Herausforderungen der Gesundheitsversorgung - Positionen der Gesundheitswirtschaft (April 2014)

PDF 92.68 KB

Stellungnahme zum Referentenentwurf "Gesetz zur Verbesserung der Versorgungsstrukturen in der gesetzlichen Krankenversicherung (GKV-VSG)" (August 2011)

PDF 887.19 KB